Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Argos Therapeutics Receives $1.5M Milestone | Contract Pharma

What are you searching for?

Sign in
Collaborations & Alliances

Argos Therapeutics Receives $1.5M Milestone

The payment was made after a successful transfer of technology related to the manufacturing of Rocapuldencel-T

By: Betsy Louda

, Contract Pharma

Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of individualized immunotherapies, has recieved a $1.5 million milestone payment from Lummy Co. Ltd. of Hong Kong. 

 

The milestone payment was made in consideration of the successful initiation of technology transfer related to the manufacturing of Rocapuldencel-T to Lummy by the Company, to which Lummy has a license for commercialization in these territories. 

 

“We appreciate Lummy’s continued commitment to Argos and the Rocapuldencel-T development program,” stated Jeff Abbey, chief executive officer of Argos. “Given the complexity of the manufacturing process for Rocapuldencel-T, we were pleased to complete this important milestone in our alliance.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters